drugset / Trial / NCT04339504
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a follow-up study to investigate the long-term safety and explore efficacy of SMUP-IA-01, for the treatment of Knee Osteoarthritis. Subjects who participated in and completed the initial stage of the Phase I trial (NCT04037345 ) will be followed-up until 60 months.
Timeline
- Start
- 2020-04-14
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SMUP-IA-01 | Cell therapy | 4e+06 cells | Other |
| Subject | SMUP-IA-01 | Cell therapy | 1e+07 cells | Other |
| Subject | SMUP-IA-01 | Cell therapy | 2e+07 cells | Other |